🇺🇸 FDA
Patent

US 7514425

Short-acting sedative hypnotic agents for anesthesia and sedation

granted A61KA61K31/216A61K31/24

Quick answer

US patent 7514425 (Short-acting sedative hypnotic agents for anesthesia and sedation) held by Theravance, Inc. expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/216, A61K31/24, A61P, A61P23/00